Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales

Ilustraciones, gráficas

Autores:
Tipo de recurso:
Fecha de publicación:
2022
Institución:
Universidad de Caldas
Repositorio:
Repositorio Institucional U. Caldas
Idioma:
eng
spa
OAI Identifier:
oai:repositorio.ucaldas.edu.co:ucaldas/17506
Acceso en línea:
https://repositorio.ucaldas.edu.co/handle/ucaldas/17506
https://repositorio.ucaldas.edu.co
Palabra clave:
Riñones
Enfermedades
Sarcopenia
Insuficiencia renal crónica
Vitamina D
Fuerza de agarre
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb
id REPOUCALDA_4cac195d3686a2267c71a9d18f8881c0
oai_identifier_str oai:repositorio.ucaldas.edu.co:ucaldas/17506
network_acronym_str REPOUCALDA
network_name_str Repositorio Institucional U. Caldas
repository_id_str
dc.title.none.fl_str_mv Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
title Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
spellingShingle Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
Riñones
Enfermedades
Sarcopenia
Insuficiencia renal crónica
Vitamina D
Fuerza de agarre
title_short Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
title_full Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
title_fullStr Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
title_full_unstemmed Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
title_sort Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de Manizales
dc.contributor.none.fl_str_mv MARULANDA MEJIA, FELIPE
Nutrición, Metabolismo y Seguridad Alimentaria (Categoría B)
dc.subject.none.fl_str_mv Riñones
Enfermedades
Sarcopenia
Insuficiencia renal crónica
Vitamina D
Fuerza de agarre
topic Riñones
Enfermedades
Sarcopenia
Insuficiencia renal crónica
Vitamina D
Fuerza de agarre
description Ilustraciones, gráficas
publishDate 2022
dc.date.none.fl_str_mv 2022-03-15T19:15:40Z
2022-09-30
2022-03-15T19:15:40Z
2022-03-15
dc.type.none.fl_str_mv Trabajo de grado - Especialización
http://purl.org/coar/resource_type/c_7a1f
Text
info:eu-repo/semantics/bachelorThesis
https://purl.org/redcol/resource_type/TP
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.identifier.none.fl_str_mv https://repositorio.ucaldas.edu.co/handle/ucaldas/17506
Universidad de Caldas
Repositorio de la Universidad de Caldas
https://repositorio.ucaldas.edu.co
url https://repositorio.ucaldas.edu.co/handle/ucaldas/17506
https://repositorio.ucaldas.edu.co
identifier_str_mv Universidad de Caldas
Repositorio de la Universidad de Caldas
dc.language.none.fl_str_mv eng
spa
language eng
spa
dc.relation.none.fl_str_mv 1. Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab [Internet]. 2014 Sep [cited 2019 Jul 25];11(3):177–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25568649
2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing [Internet]. 2010 Jul 1 [cited 2019 Jul 25];39(4):412–23. Available from: https://academic.oup.com/ageing/article-lookup/doi/10.1093/ageing/afq034
3. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet [Internet]. 2019 Jun 29 [cited 2019 Oct 9];393(10191):2636–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31171417
4. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing [Internet]. 2019 Jan 1 [cited 2019 Jul 25];48(1):16–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30312372
5. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr [Internet]. 2010 Apr [cited 2019 Jul 25];29(2):154–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20060626
6. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc [Internet]. 2011 May [cited 2019 Jul 25];12(4):249–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21527165
7. Reinders I, Murphy RA, Brouwer IA, Visser M, Launer L, Siggeirsdottir K, et al. Muscle Quality and Myosteatosis: Novel Associations With Mortality Risk: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. Am J Epidemiol [Internet]. 2016 Jan 1 [cited 2022 Feb 7];183(1):53–60. Available from: https://pubmed.ncbi.nlm.nih.gov/26643983/
8. Heymsfield SB, Gonzalez MC, Lu J, Jia G, Zheng J. Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia. Proc Nutr Soc [Internet]. 2015 Nov 1 [cited 2022 Feb 7];74(4):355–66. Available from: https://www.cambridge.org/core/journals/proceedings-of-the-nutritionsociety/article/skeletal-muscle-mass-and-quality-evolution-of-modernmeasurement-concepts-in-the-context-ofsarcopenia/3AA70B0C0FDDF1BDA7B7B2B5131533CD
9. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation. Transplantation [Internet]. 2017 [cited 2022 Feb 7];101(3):565–74. Available from: https://pubmed.ncbi.nlm.nih.gov/27926595/
10. Villada-Gómez JS, González-Correa CH, Pineda-Zuluaga MC. Electrical Bioimpedance Phase Angle and Sarcopenia Diagnostic in Functional Elderly. J Phys Conf Ser [Internet]. 2021 Aug 1 [cited 2022 Feb 7];2008(1):012004. Available from: https://iopscience.iop.org/article/10.1088/1742- 6596/2008/1/012004
11. Parra-Rodríguez L, Szlejf C, García-González AI, Malmstrom TK, CruzArenas E, Rosas-Carrasco O. Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J Am Med Dir Assoc [Internet]. 2016 Dec 1 [cited 2019 Oct 9];17(12):1142–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27815111
12. Gonzalez MC, Barbosa-Silva TG, Heymsfield SB. Bioelectrical impedance analysis in the assessment of sarcopenia. Curr Opin Clin Nutr Metab Care. 2019;21(5):366–74.
13. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89(2):465–71.
14. Achamrah N, Colange G, Delay J, Rimbert A, Folope V, Petit A, et al. Comparison of body composition assessment by DXA and BIA according to the body mass index: A retrospective study on 3655 measures. PLoS One. 2018;13(7):1–13.
15. López-Gómez JM. Evolución y aplicaciones de la bioimpedancia en el manejo de la enfermedad renal crónica. Nefrologia. 2011;31(6):630–4
16. Villada-Gómez JS, González-Correa CH, Marulanda-Mejía F. Puntos de corte provisionales para el diagnóstico de sarcopenia en ancianos de Caldas, Colombia. Biomedica. 2018;38(4):521–6.
17. Guerri S, Mercatelli D, Gómez MPA, Napoli A, Battista G, Guglielmi G, et al. Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia. Quant Imaging Med Surg. 2018;8(1):60–85.
18. de Souza Barbosa JF, Zepeda MUP, Béland F, Guralnik JM, Zunzunegui MV, Guerra RO. Clinically relevant weakness in diverse populations of older adults participating in the International Mobility in Aging Study. Age (Omaha). 2016;38(1):1–15.
19. Gómez JF, Curcio C-L, Alvarado B, Zunzunegui MV, Guralnik J. Validity and reliability of the Short Physical Performance Battery (SPPB): a pilot study on 35 mobility in the Colombian Andes. Colomb medica (Cali, Colomb [Internet]. 2013;44(3):165–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24892614%0Ahttp://www.pubmedcentr al.nih.gov/articlerender.fcgi?artid=PMC4002038
20. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010 Jul 1;39(4):412–23.
21. De Souza VA, Oliveira D, Barbosa SR, Corrêa JODA, Colugnati FAB, Mansur HN, et al. Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors. PLoS One. 2017;12(4):1–13.
22. Cuenta de alto costo. Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus. Cuenta alto costo [Internet]. 2017;280. Available from: https://cuentadealtocosto.org/site/images/Publicaciones/2018/Libro_Situacio n_ERC_en_Colombia_2017.pdf
23. Ortiz A, Sanchez-Niño MD. Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials. Clin Kidney J [Internet]. 2019 Feb [cited 2019 Jul 25];12(1):110–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30746137
24. Tanaka S, Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Ichinosawa Y, et al. SARC-F questionnaire identifies physical limitations and predicts post discharge outcomes in elderly patients with cardiovascular disease. JCSM Clin Reports. 2018;3(1).
25. Nogueira Á, Álvarez G, Russo F, San-José B, Sánchez-Tomero JA, Barril G. ¿Es útil el SPPB como método de screening de capacidad funcional en pacientes con enfermedad renal crónica avanzada? Nefrología. 2019;39(5):489–96.
26. Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens [Internet]. 2017 [cited 2019 Oct 11];26(3):219–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28198733
27. Braga M, Simmons Z, Norris KC, Ferrini MG, Artaza JN. Vitamin D induces myogenic differentiation in skeletal muscle derived stem cells. Endocr Connect. 2017;6(3):139–50.
28. Dawson-Hughes B. Vitamin D and muscle function. J Steroid Biochem Mol Biol [Internet]. 2017;173(March):313–6. Available from: http://dx.doi.org/10.1016/j.jsbmb.2017.03.018
29. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 2020 344 [Internet]. 2020 Sep 2 [cited 2022 Feb 9];34(4):1347–72. Available from: 36 https://link.springer.com/article/10.1007/s40620-020-00840-y
30. Franca Gois PH, Wolley M, Ranganathan D, Seguro AC. Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Int J Environ Res Public Health [Internet]. 2018 [cited 2019 Jul 25];15(8). Available from: http://www.ncbi.nlm.nih.gov/pubmed/30126163
31. Valencia CAR, Arango JVA. Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5. Colomb Med [Internet]. 2019 [cited 2019 Oct 9];50(1):49. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657- 95342016000300160
32. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 2020 344. 2020 Sep;34(4):1347–72.
33. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol [Internet]. 2008 Jul 1 [cited 2019 Jul 25];3(4):1144–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18417740
34. Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial. J Am Med Dir Assoc [Internet]. 2015;16(9):740–7. Available from: http://dx.doi.org/10.1016/j.jamda.2015.05.021
35. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol [Internet]. 2009 Feb [cited 2019 Jul 25];19(2):73– 8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18329892
36. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr [Internet]. 2006 Jun 1 [cited 2019 Jul 25];84(1):18–28. Available from: https://academic.oup.com/ajcn/article/84/1/18/4633029
37. Holick MF. Vitamin D Deficiency. N Engl J Med [Internet]. 2007 Jul 19 [cited 2019 Jul 25];357(3):266–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17634462
38. Ogan D, Pritchett K. Vitamin D and the Athlete: Risks, Recommendations, and Benefits. Nutrients [Internet]. 2013 May 28 [cited 2022 Feb 7];5(6):1856. Available from: /pmc/articles/PMC3725481/
39. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating Vitamin D3 and 25-hydroxyvitamin D in Humans: An Important Tool to Define Adequate Nutritional Vitamin D Status. J Steroid Biochem Mol Biol [Internet]. 2007 Mar [cited 2022 Feb 27];103(3–5):631. Available from: 37 /pmc/articles/PMC1868557/
40. Cannell JJ, Hollis BW, Sorenson MB, Taft TN, Anderson JJB. Athletic performance and vitamin D. Med Sci Sports Exerc [Internet]. 2009 May [cited 2022 Feb 7];41(5):1102–10. Available from: https://pubmed.ncbi.nlm.nih.gov/19346976/
41. Conzade R, Grill E, Bischoff-Ferrari HA, Ferrari U, Horsch A, Koenig W, et al. Vitamin D in Relation to Incident Sarcopenia and Changes in Muscle Parameters Among Older Adults: The KORA-Age Study. Calcif Tissue Int [Internet]. 2019 May 8 [cited 2019 Jul 25]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/31069442
42. Gielen E, O’Neill TW, Pye SR, Adams JE, Wu FC, Laurent MR, et al. Endocrine determinants of incident sarcopenia in middle-aged and elderly European men. J Cachexia Sarcopenia Muscle [Internet]. 2015 Sep [cited 2019 Jul 25];6(3):242–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26401471
43. Hirani V, Cumming RG, Naganathan V, Blyth F, Le Couteur DG, Hsu B, et al. Longitudinal Associations Between Vitamin D Metabolites and Sarcopenia in Older Australian men: The Concord Health and Aging in Men Project. Journals Gerontol Ser A [Internet]. 2018 Jan 1 [cited 2019 Jul 25];73(1):131– 8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28549108
44. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul 1;96(7):1911–30.
45. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and metaanalysis of general population studies. J Diabetes Metab Disord [Internet]. 2017 May 16 [cited 2022 Feb 23];16(1). Available from: /pmc/articles/PMC5434551/
46. González-González DR, López-Salazar AM G-CC. Resultados preliminares de un estudio sobre prevalencia de sarcopenia en ancianos. Rev Asoc Colomb Gerontol Geriatr. 2015;29(2023):33.
47. Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc [Internet]. 2008 Sep [cited 2022 Feb 23];56(9):1710–5. Available from: https://pubmed.ncbi.nlm.nih.gov/18691288/
48. Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant [Internet]. 2015 Oct 1 [cited 2022 Feb 9];30(10):1718–25. Available from: 38 https://pubmed.ncbi.nlm.nih.gov/25999376/
49. An JN, Kim JK, Lee HS, Kim SG, Kim HJ, Song YR. Late stage 3 chronic kidney disease is an independent risk factor for sarcopenia, but not proteinuria. Sci Rep [Internet]. 2021 Dec 1 [cited 2022 Feb 28];11(1). Available from: /pmc/articles/PMC8446068/
50. Yu MD, Zhang HZ, Zhang Y, Yang SP, Lin M, Zhang YM, et al. Relationship between chronic kidney disease and sarcopenia. Sci Reports 2021 111 [Internet]. 2021 Oct 15 [cited 2022 Feb 9];11(1):1–7. Available from: https://www.nature.com/articles/s41598-021-99592-3
51. Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, et al. Sarcopenia: A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle [Internet]. 2019 Oct 1 [cited 2022 Feb 9];10(5):956–61. Available from: https://pubmed.ncbi.nlm.nih.gov/31523937/
52. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol [Internet]. 2019 [cited 2022 Feb 9];1165:3–15. Available from: https://pubmed.ncbi.nlm.nih.gov/31399958/
53. Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr [Internet]. 2014 Feb [cited 2022 Feb 9];33(1):64–8. Available from: https://pubmed.ncbi.nlm.nih.gov/23631844/
54. McGregor RA, Cameron-Smith D, Poppitt SD. It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life. Longev Heal [Internet]. 2014 Dec 1 [cited 2022 Feb 12];3(1). Available from: /pmc/articles/PMC4268803/
55. Akamatsu Y, Kusakabe T, Arai H, Yamamoto Y, Nakao K, Ikeue K, et al. Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. J Cachexia Sarcopenia Muscle [Internet]. 2022 Feb 1 [cited 2022 Feb 12];13(1):180–9. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.12860
56. Barbat-Artigas S, Rolland Y, Vellas B, Aubertin-Leheudre M. Muscle Quantity Is Not Synonymous With Muscle Quality. J Am Med Dir Assoc [Internet]. 2013 Nov 1 [cited 2022 Feb 12];14(11):852.e1-852.e7. Available from: http://www.jamda.com/article/S1525861013003460/fulltext
57. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr [Internet]. 2006 Jun 1 [cited 2022 Feb 12];84(1):18–28. Available from: https://academic.oup.com/ajcn/article/84/1/18/4633029
58. Bo Y, Liu C, Ji Z, Yang R, An Q, Zhang X, et al. A high whey protein, vitamin D and E supplement preserves muscle mass, strength, and quality of life in 39 sarcopenic older adults: A double-blind randomized controlled trial. Clin Nutr [Internet]. 2019 Feb 1 [cited 2022 Feb 9];38(1):159–64. Available from: https://pubmed.ncbi.nlm.nih.gov/29395372/
59. Kidney International Supplements. Official Journal of the international Society of nephrology KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. IFAC Proc Vol [Internet]. 2013 [cited 2022 Mar 8];3(1):30–130. Available from: www.publicationethics.org
60. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr [Internet]. 2013 Mar [cited 2022 Mar 8];23(2):77–90. Available from: https://pubmed.ncbi.nlm.nih.gov/23428357/
61. Ramírez Castaño J, Restrepo Valencia CA, González Correa CH, Marulanda Mejía F, Chacón Cardona JA, Ramírez Castaño J, et al. Desgaste proteico energético en pacientes con enfermedad renal crónica en estadios III a IV en Caldas, Colombia. Rev Colomb Nefrol [Internet]. 2020 Aug 5 [cited 2022 Mar 8];7(2):67–77. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S2500- 50062020000200067&lng=en&nrm=iso&tlng=es
dc.rights.none.fl_str_mv info:eu-repo/semantics/closedAccess
info:eu-repo/semantics/closedAccess
info:eu-repo/semantics/closedAccess
info:eu-repo/semantics/closedAccess
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
rights_invalid_str_mv http://purl.org/coar/access_right/c_14cb
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Facultad de Ciencias para la Salud
Manizales
Especialización Medicina Interna
publisher.none.fl_str_mv Facultad de Ciencias para la Salud
Manizales
Especialización Medicina Interna
institution Universidad de Caldas
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1836145045290352640
spelling Relación entre hipovitaminosis D y sarcopenia en pacientes con enfermedad renal crónica estadio 3 y 4 de la ciudad de ManizalesRiñonesEnfermedadesSarcopeniaInsuficiencia renal crónicaVitamina DFuerza de agarreIlustraciones, gráficasspa: Objetivo: Determinar la frecuencia de sarcopenia en pacientes con ERC estadio 3 y 4 y su asociación con hipovitaminosis D en pacientes de consulta de nefrología de la ciudad de Manizales. Metodología: Se realizó un estudio observacional de corte transversal y analítico, a partir de pacientes inscritos en una base de datos de consulta especializada de nefrología de la ciudad de Manizales, Colombia. Se incluyeron personas mayores de 18 años que tenían enfermedad renal crónica en estadio 3 o 4. Se excluyeron del presente estudio a aquellos pacientes con inestabilidad hemodinámica o clínica, VIH/SIDA, neuropatía severa, enfermedad hepática, secuelas de ACV, artritis, osteoartritis, amputaciones, EPOC severa, enfermedad de Parkinson, cáncer, discapacidad para la marcha o la negativa para firmar el consentimiento informado. Se realizó un muestreo no probabilístico a conveniencia teniendo en cuenta los escasos datos esperados para los criterios de inclusión establecidos. La recolección de los datos se realizó entre enero de 2020 a octubre de 2021, luego se trasladaron al programa estadístico IBM SPSS statics versión 22.0. Se realizó un análisis de variables cuantitativas con medidas de tendencia central y dispersión y las variables cualitativas a través de tablas de frecuencia. Resultados: Se recolectaron 101 pacientes con enfermedad renal crónica estadio 3 o 4. La frecuencia de sarcopenia en pacientes con ERC estadio 3 y 4 fue 10,9%. Se encontró relación directa entre la dinapenia y la hipovitaminosis D, a su vez, se encontró relación directa entre sarcopenia severa con la hipovitaminosis D. La suplencia de vitamina D no tuvo impacto sobre el desempeño muscular. Conclusiones: La sarcopenia es una condición asociada al envejecimiento y a múltiples condiciones médicas como la ERC. Se sabe que la hipovitaminosis D es un factor importante para la fuerza muscular. No se encontró relación directa entre sarcopenia y niveles séricos de vitamina D. Niveles séricos de vitamina D por encima de 40 ng/ml se asociaron con mejor desempeño muscular y en consecuencia probable mejor calidad de vida, funcionalidad y menor riesgo de fragilidad.eng: Sarcopenia is a condition associated with aging and multiple medical conditions such as CKD and hypovitaminosis D. An observational cross-sectional study was carried out, based on patients registered in a database of specialized nephrology consultation in the city of Manizales, Colombia. 101 patients over 18 years of age who had stage 3 or 4 CKD were included. The frequency of sarcopenia was 10.9%. A direct relationship was found between dynapenia and hypovitaminosis D, in turn, a direct relationship was found between severe sarcopenia and hypovitaminosis D. Vitamin D supplementation had no impact on muscle performance. No direct relationship was found between sarcopenia and serum vitamin D levels. Serum vitamin D levels greater than 40 ng/mL were associated with better muscle performance and, consequently, probably with better quality of life, function, and lower risk of frailty.Resumen/ Introducción/ Marco teórico/ Planteamiento del problema / Pregunta de investigación/ Justificación / Objetivo general/ Objetivos específicos/ Métodos/ Resultados/Discusión/Conclusiones y recomendaciones / Bibliografía/Anexos.EspecializaciónEspecialista Medicina InternaSarcopeniaFacultad de Ciencias para la SaludManizalesEspecialización Medicina InternaMARULANDA MEJIA, FELIPENutrición, Metabolismo y Seguridad Alimentaria (Categoría B)Álvarez Mejía, MiguelMARULANDA MEJIA, FELIPEGonzalez-Correa, Clara HelenaCHACON CARDONA, JOSE ARNOBYRestrepo Valencia, Cesar AugustoGómez Tobón, Pamela2022-03-15T19:15:40Z2022-09-302022-03-15T19:15:40Z2022-03-15Trabajo de grado - Especializaciónhttp://purl.org/coar/resource_type/c_7a1fTextinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPhttp://purl.org/coar/version/c_970fb48d4fbd8a85application/pdfapplication/pdfapplication/pdfapplication/pdfhttps://repositorio.ucaldas.edu.co/handle/ucaldas/17506Universidad de CaldasRepositorio de la Universidad de Caldashttps://repositorio.ucaldas.edu.coengspa1. Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab [Internet]. 2014 Sep [cited 2019 Jul 25];11(3):177–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/255686492. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing [Internet]. 2010 Jul 1 [cited 2019 Jul 25];39(4):412–23. Available from: https://academic.oup.com/ageing/article-lookup/doi/10.1093/ageing/afq0343. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet [Internet]. 2019 Jun 29 [cited 2019 Oct 9];393(10191):2636–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/311714174. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing [Internet]. 2019 Jan 1 [cited 2019 Jul 25];48(1):16–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/303123725. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr [Internet]. 2010 Apr [cited 2019 Jul 25];29(2):154–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/200606266. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc [Internet]. 2011 May [cited 2019 Jul 25];12(4):249–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/215271657. Reinders I, Murphy RA, Brouwer IA, Visser M, Launer L, Siggeirsdottir K, et al. Muscle Quality and Myosteatosis: Novel Associations With Mortality Risk: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. Am J Epidemiol [Internet]. 2016 Jan 1 [cited 2022 Feb 7];183(1):53–60. Available from: https://pubmed.ncbi.nlm.nih.gov/26643983/8. Heymsfield SB, Gonzalez MC, Lu J, Jia G, Zheng J. Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia. Proc Nutr Soc [Internet]. 2015 Nov 1 [cited 2022 Feb 7];74(4):355–66. Available from: https://www.cambridge.org/core/journals/proceedings-of-the-nutritionsociety/article/skeletal-muscle-mass-and-quality-evolution-of-modernmeasurement-concepts-in-the-context-ofsarcopenia/3AA70B0C0FDDF1BDA7B7B2B5131533CD9. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation. Transplantation [Internet]. 2017 [cited 2022 Feb 7];101(3):565–74. Available from: https://pubmed.ncbi.nlm.nih.gov/27926595/10. Villada-Gómez JS, González-Correa CH, Pineda-Zuluaga MC. Electrical Bioimpedance Phase Angle and Sarcopenia Diagnostic in Functional Elderly. J Phys Conf Ser [Internet]. 2021 Aug 1 [cited 2022 Feb 7];2008(1):012004. Available from: https://iopscience.iop.org/article/10.1088/1742- 6596/2008/1/01200411. Parra-Rodríguez L, Szlejf C, García-González AI, Malmstrom TK, CruzArenas E, Rosas-Carrasco O. Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J Am Med Dir Assoc [Internet]. 2016 Dec 1 [cited 2019 Oct 9];17(12):1142–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2781511112. Gonzalez MC, Barbosa-Silva TG, Heymsfield SB. Bioelectrical impedance analysis in the assessment of sarcopenia. Curr Opin Clin Nutr Metab Care. 2019;21(5):366–74.13. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89(2):465–71.14. Achamrah N, Colange G, Delay J, Rimbert A, Folope V, Petit A, et al. Comparison of body composition assessment by DXA and BIA according to the body mass index: A retrospective study on 3655 measures. PLoS One. 2018;13(7):1–13.15. López-Gómez JM. Evolución y aplicaciones de la bioimpedancia en el manejo de la enfermedad renal crónica. Nefrologia. 2011;31(6):630–416. Villada-Gómez JS, González-Correa CH, Marulanda-Mejía F. Puntos de corte provisionales para el diagnóstico de sarcopenia en ancianos de Caldas, Colombia. Biomedica. 2018;38(4):521–6.17. Guerri S, Mercatelli D, Gómez MPA, Napoli A, Battista G, Guglielmi G, et al. Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia. Quant Imaging Med Surg. 2018;8(1):60–85.18. de Souza Barbosa JF, Zepeda MUP, Béland F, Guralnik JM, Zunzunegui MV, Guerra RO. Clinically relevant weakness in diverse populations of older adults participating in the International Mobility in Aging Study. Age (Omaha). 2016;38(1):1–15.19. Gómez JF, Curcio C-L, Alvarado B, Zunzunegui MV, Guralnik J. Validity and reliability of the Short Physical Performance Battery (SPPB): a pilot study on 35 mobility in the Colombian Andes. Colomb medica (Cali, Colomb [Internet]. 2013;44(3):165–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24892614%0Ahttp://www.pubmedcentr al.nih.gov/articlerender.fcgi?artid=PMC400203820. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010 Jul 1;39(4):412–23.21. De Souza VA, Oliveira D, Barbosa SR, Corrêa JODA, Colugnati FAB, Mansur HN, et al. Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors. PLoS One. 2017;12(4):1–13.22. Cuenta de alto costo. Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus. Cuenta alto costo [Internet]. 2017;280. Available from: https://cuentadealtocosto.org/site/images/Publicaciones/2018/Libro_Situacio n_ERC_en_Colombia_2017.pdf23. Ortiz A, Sanchez-Niño MD. Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials. Clin Kidney J [Internet]. 2019 Feb [cited 2019 Jul 25];12(1):110–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3074613724. Tanaka S, Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Ichinosawa Y, et al. SARC-F questionnaire identifies physical limitations and predicts post discharge outcomes in elderly patients with cardiovascular disease. JCSM Clin Reports. 2018;3(1).25. Nogueira Á, Álvarez G, Russo F, San-José B, Sánchez-Tomero JA, Barril G. ¿Es útil el SPPB como método de screening de capacidad funcional en pacientes con enfermedad renal crónica avanzada? Nefrología. 2019;39(5):489–96.26. Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens [Internet]. 2017 [cited 2019 Oct 11];26(3):219–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2819873327. Braga M, Simmons Z, Norris KC, Ferrini MG, Artaza JN. Vitamin D induces myogenic differentiation in skeletal muscle derived stem cells. Endocr Connect. 2017;6(3):139–50.28. Dawson-Hughes B. Vitamin D and muscle function. J Steroid Biochem Mol Biol [Internet]. 2017;173(March):313–6. Available from: http://dx.doi.org/10.1016/j.jsbmb.2017.03.01829. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 2020 344 [Internet]. 2020 Sep 2 [cited 2022 Feb 9];34(4):1347–72. Available from: 36 https://link.springer.com/article/10.1007/s40620-020-00840-y30. Franca Gois PH, Wolley M, Ranganathan D, Seguro AC. Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Int J Environ Res Public Health [Internet]. 2018 [cited 2019 Jul 25];15(8). Available from: http://www.ncbi.nlm.nih.gov/pubmed/3012616331. Valencia CAR, Arango JVA. Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5. Colomb Med [Internet]. 2019 [cited 2019 Oct 9];50(1):49. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657- 9534201600030016032. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 2020 344. 2020 Sep;34(4):1347–72.33. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol [Internet]. 2008 Jul 1 [cited 2019 Jul 25];3(4):1144–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1841774034. Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial. J Am Med Dir Assoc [Internet]. 2015;16(9):740–7. Available from: http://dx.doi.org/10.1016/j.jamda.2015.05.02135. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol [Internet]. 2009 Feb [cited 2019 Jul 25];19(2):73– 8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1832989236. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr [Internet]. 2006 Jun 1 [cited 2019 Jul 25];84(1):18–28. Available from: https://academic.oup.com/ajcn/article/84/1/18/463302937. Holick MF. Vitamin D Deficiency. N Engl J Med [Internet]. 2007 Jul 19 [cited 2019 Jul 25];357(3):266–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1763446238. Ogan D, Pritchett K. Vitamin D and the Athlete: Risks, Recommendations, and Benefits. Nutrients [Internet]. 2013 May 28 [cited 2022 Feb 7];5(6):1856. Available from: /pmc/articles/PMC3725481/39. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating Vitamin D3 and 25-hydroxyvitamin D in Humans: An Important Tool to Define Adequate Nutritional Vitamin D Status. J Steroid Biochem Mol Biol [Internet]. 2007 Mar [cited 2022 Feb 27];103(3–5):631. Available from: 37 /pmc/articles/PMC1868557/40. Cannell JJ, Hollis BW, Sorenson MB, Taft TN, Anderson JJB. Athletic performance and vitamin D. Med Sci Sports Exerc [Internet]. 2009 May [cited 2022 Feb 7];41(5):1102–10. Available from: https://pubmed.ncbi.nlm.nih.gov/19346976/41. Conzade R, Grill E, Bischoff-Ferrari HA, Ferrari U, Horsch A, Koenig W, et al. Vitamin D in Relation to Incident Sarcopenia and Changes in Muscle Parameters Among Older Adults: The KORA-Age Study. Calcif Tissue Int [Internet]. 2019 May 8 [cited 2019 Jul 25]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/3106944242. Gielen E, O’Neill TW, Pye SR, Adams JE, Wu FC, Laurent MR, et al. Endocrine determinants of incident sarcopenia in middle-aged and elderly European men. J Cachexia Sarcopenia Muscle [Internet]. 2015 Sep [cited 2019 Jul 25];6(3):242–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2640147143. Hirani V, Cumming RG, Naganathan V, Blyth F, Le Couteur DG, Hsu B, et al. Longitudinal Associations Between Vitamin D Metabolites and Sarcopenia in Older Australian men: The Concord Health and Aging in Men Project. Journals Gerontol Ser A [Internet]. 2018 Jan 1 [cited 2019 Jul 25];73(1):131– 8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2854910844. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul 1;96(7):1911–30.45. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and metaanalysis of general population studies. J Diabetes Metab Disord [Internet]. 2017 May 16 [cited 2022 Feb 23];16(1). Available from: /pmc/articles/PMC5434551/46. González-González DR, López-Salazar AM G-CC. Resultados preliminares de un estudio sobre prevalencia de sarcopenia en ancianos. Rev Asoc Colomb Gerontol Geriatr. 2015;29(2023):33.47. Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc [Internet]. 2008 Sep [cited 2022 Feb 23];56(9):1710–5. Available from: https://pubmed.ncbi.nlm.nih.gov/18691288/48. Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant [Internet]. 2015 Oct 1 [cited 2022 Feb 9];30(10):1718–25. Available from: 38 https://pubmed.ncbi.nlm.nih.gov/25999376/49. An JN, Kim JK, Lee HS, Kim SG, Kim HJ, Song YR. Late stage 3 chronic kidney disease is an independent risk factor for sarcopenia, but not proteinuria. Sci Rep [Internet]. 2021 Dec 1 [cited 2022 Feb 28];11(1). Available from: /pmc/articles/PMC8446068/50. Yu MD, Zhang HZ, Zhang Y, Yang SP, Lin M, Zhang YM, et al. Relationship between chronic kidney disease and sarcopenia. Sci Reports 2021 111 [Internet]. 2021 Oct 15 [cited 2022 Feb 9];11(1):1–7. Available from: https://www.nature.com/articles/s41598-021-99592-351. Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, et al. Sarcopenia: A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle [Internet]. 2019 Oct 1 [cited 2022 Feb 9];10(5):956–61. Available from: https://pubmed.ncbi.nlm.nih.gov/31523937/52. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol [Internet]. 2019 [cited 2022 Feb 9];1165:3–15. Available from: https://pubmed.ncbi.nlm.nih.gov/31399958/53. Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr [Internet]. 2014 Feb [cited 2022 Feb 9];33(1):64–8. Available from: https://pubmed.ncbi.nlm.nih.gov/23631844/54. McGregor RA, Cameron-Smith D, Poppitt SD. It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life. Longev Heal [Internet]. 2014 Dec 1 [cited 2022 Feb 12];3(1). Available from: /pmc/articles/PMC4268803/55. Akamatsu Y, Kusakabe T, Arai H, Yamamoto Y, Nakao K, Ikeue K, et al. Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. J Cachexia Sarcopenia Muscle [Internet]. 2022 Feb 1 [cited 2022 Feb 12];13(1):180–9. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.1286056. Barbat-Artigas S, Rolland Y, Vellas B, Aubertin-Leheudre M. Muscle Quantity Is Not Synonymous With Muscle Quality. J Am Med Dir Assoc [Internet]. 2013 Nov 1 [cited 2022 Feb 12];14(11):852.e1-852.e7. Available from: http://www.jamda.com/article/S1525861013003460/fulltext57. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr [Internet]. 2006 Jun 1 [cited 2022 Feb 12];84(1):18–28. Available from: https://academic.oup.com/ajcn/article/84/1/18/463302958. Bo Y, Liu C, Ji Z, Yang R, An Q, Zhang X, et al. A high whey protein, vitamin D and E supplement preserves muscle mass, strength, and quality of life in 39 sarcopenic older adults: A double-blind randomized controlled trial. Clin Nutr [Internet]. 2019 Feb 1 [cited 2022 Feb 9];38(1):159–64. Available from: https://pubmed.ncbi.nlm.nih.gov/29395372/59. Kidney International Supplements. Official Journal of the international Society of nephrology KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. IFAC Proc Vol [Internet]. 2013 [cited 2022 Mar 8];3(1):30–130. Available from: www.publicationethics.org60. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr [Internet]. 2013 Mar [cited 2022 Mar 8];23(2):77–90. Available from: https://pubmed.ncbi.nlm.nih.gov/23428357/61. Ramírez Castaño J, Restrepo Valencia CA, González Correa CH, Marulanda Mejía F, Chacón Cardona JA, Ramírez Castaño J, et al. Desgaste proteico energético en pacientes con enfermedad renal crónica en estadios III a IV en Caldas, Colombia. Rev Colomb Nefrol [Internet]. 2020 Aug 5 [cited 2022 Mar 8];7(2):67–77. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S2500- 50062020000200067&lng=en&nrm=iso&tlng=esinfo:eu-repo/semantics/closedAccessinfo:eu-repo/semantics/closedAccessinfo:eu-repo/semantics/closedAccessinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cboai:repositorio.ucaldas.edu.co:ucaldas/175062024-09-21T03:35:59Z

Publicaciones similares